U.S. cuts childhood vaccine recommendations, drawing sharp criticism from physicians

What changed in the vaccine schedule

The U.S. government has revised its childhood vaccination guidance, reducing the number of vaccines broadly recommended for all children from 17 to 11, according to an Associated Press report published earlier this month. The change was described as effective immediately and shifts several common immunizations away from universal recommendation toward either high-risk targeting or case-by-case discussion between families and clinicians.

The AP reported that the CDC would no longer broadly advise vaccinations against influenza, rotavirus, hepatitis A, hepatitis B, RSV, and some forms of meningitis, instead limiting those recommendations to certain groups deemed high risk or to what officials described as “shared decision-making” with doctors. Administration officials said families who want the vaccines would still be able to get them and that insurance coverage would continue.

Who pushed the overhaul, and why

The report linked the shift to the Trump administration and Health Secretary Robert F. Kennedy Jr., with officials framing the move as an effort to rebuild trust and align U.S. practice more closely with certain peer nations. The administration argued that the U.S. had become an outlier in the number of vaccinations and doses recommended to all children and suggested a narrower schedule would strengthen credibility by focusing on what it considers the most important protections.

Public trust has become a central political and public-health battleground in recent years, especially as misinformation and polarization have influenced vaccine uptake. The AP noted that childhood vaccination rates in the U.S. have been slipping and that exemptions have reached record levels, while outbreaks of diseases preventable by vaccines have been rising.

Why physicians and health groups object

Medical experts and leading physician groups strongly criticized the change, warning it could lead to more illness and deaths from preventable diseases and could undermine confidence in vaccination overall. Critics described the process as lacking transparency and scientific rigor, arguing that changes appeared to bypass established advisory mechanisms and expert review norms used to evaluate risks and benefits.

Clinicians also warned that narrowing universal recommendations can create confusion: parents may interpret a shift in policy as evidence that vaccines are unsafe or unnecessary, even if the medical community continues to view them as valuable protections. The AP noted that groups such as the American Academy of Pediatrics and the American Medical Association continued to support broader vaccine use, emphasizing risks posed by illnesses like flu and rotavirus in particular.

What families may face next

In practical terms, the shift could place more burden on pediatric visits, requiring more individualized counseling and documentation about what is recommended, when, and for whom. It could also influence school and childcare vaccination expectations depending on how states respond, and it may affect public understanding of which shots are considered standard childhood care.

The policy debate is likely to intensify as experts weigh potential outcomes, including whether reduced universal recommendations lead to measurable changes in uptake and whether that correlates with larger outbreaks. In the meantime, doctors are preparing for difficult conversations with parents seeking clarity on why long-standard recommendations were changed and what it means for protecting children and communities.